In fact, the mean frequency of IL-6+ cells under US conditions, as well as following CD40L stimulation, was 60% of that of the total non-classical monocytes in NMOSD, which is three-fold higher than that of MS and HC monocytes (Additional file 1: Figure S3). This evidence concerns the gene CD40LG and myeloid sarcoma.